Synthesis and biological evaluation of (E)-cinnamic acid, (E)-2-styrylthiazole and (E)-2-[2-(naphthalen-1-yl)vinyl]thiazole derivatives

dc.contributor.authorOlawode, Emmanuel O.
dc.contributor.authorTandlich, Roman
dc.contributor.authorPrinsloo, Earl
dc.contributor.authorIsaacs, Michelle
dc.contributor.authorHoppe, Heinrich
dc.contributor.authorSeldon, Ronnett
dc.contributor.authorWarner, Digby F.
dc.contributor.authorSteenkamp, Vanessa
dc.contributor.authorKaye, Perry T.
dc.date.accessioned2017-11-20T13:18:30Z
dc.date.available2017-11-20T13:18:30Z
dc.date.issued2017-04
dc.description.abstractCinnamyl- and thiazole-based compounds have been shown to exhibit diverse medicinal properties and a series of twelve (E)-2-styrylthiazole and (E)-2-[(naphthalen-1-yl)vinyl]thiazole derivatives, which are conjugates of both systems and which satisfy the “Lipinski rule of 5”, have been synthesised and subjected to in vitro biological screening. While insignificant inhibition (60-98% viability at 10 μM) of HeLa (cervical cancer) cells was noted, all five of the (E)-2-[naphthalen-1- yl)vinyl]thiazole derivatives proved remarkably active against SH-SY5Y (neuroblastoma) cells with IC50 values ranging from 2.09 to 8.64 μM. Two of the seven (E)-2-styrylthiazoles were found to be moderately active (with IC50 values of 10.8 and 11.7 mM), whereas the remaining five analogues exhibit significant proliferation of SH-SY5Y cells (with IC50 values of 180-1000 mM). The results warrant further studies on the effects of styrylthiazoles on the differentiation and extension of SH-SY5Y cells in order to assess their activity in neurological degenerative diseases.en_ZA
dc.description.departmentPharmacologyen_ZA
dc.description.librarianam2017en_ZA
dc.description.sponsorshipRhodes University for a bursary (E. O. O) and Rhodes University and the South African Medical Research Council (MRC) for generous financial support. This research project was supported by the South African Medical Research Council (MRC) with funds from National Treasury under its Economic Competitiveness and Support Package. The xCELLigence Real-Time Cell Analyzer SP Station was supported through the National Research Foundation (NRF) - Department of Science & Technology (DST) Research Infrastructure Support Programme (National Nanotechnology Equipment Programme) grant.en_ZA
dc.description.urihttp://www.arkat-usa.orgen_ZA
dc.identifier.citationOlawode, E.O. et al. 2017, 'Synthesis and biological evaluation of (E)-cinnamic acid, (E)-2-styrylthiazole and (E)-2-[2-(naphthalen-1-yl)vinyl]thiazole derivatives', Arkivoc, Part vi. pp. 284-296.en_ZA
dc.identifier.issn1551-7012 (print)
dc.identifier.issn1551-7004 (online)
dc.identifier.other10.3998/ark.5550190.p009.905
dc.identifier.urihttp://hdl.handle.net/2263/63240
dc.language.isoenen_ZA
dc.publisherMichigan Publishingen_ZA
dc.rights© ARKAT-USA, Inc. Published with a Creative Commons Attribution Non-Commercial License.en_ZA
dc.subjectSynthesisen_ZA
dc.subjectCinnamic acidsen_ZA
dc.subjectStyrylthiazolesen_ZA
dc.subject2-[2-(Naphthalen-1-yl)vinyl]thiazolesen_ZA
dc.subjectBiological activityen_ZA
dc.subjectPeptidesen_ZA
dc.subjectPlasmodium falciparumen_ZA
dc.titleSynthesis and biological evaluation of (E)-cinnamic acid, (E)-2-styrylthiazole and (E)-2-[2-(naphthalen-1-yl)vinyl]thiazole derivativesen_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Olawode_Synthesis_2017.pdf
Size:
933.15 KB
Format:
Adobe Portable Document Format
Description:
Article
Loading...
Thumbnail Image
Name:
Olawode_SynthesisSuppl_2017.pdf
Size:
1.14 MB
Format:
Adobe Portable Document Format
Description:
Supplementary Material

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: